Lithuania - Lipid Modifying Medicine Use
Since 2014, Lithuania Lipid Modifying Medicine Use increased 18.8% year on year. With 46.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 27 comparing other countries in Lipid Modifying Medicine Use. Lithuania is overtaken by Estonia, which was number 26 at 69.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Turkey with 23 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark lead the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, an increase of 3.5% versus 2018. United Kingdom, Norway and Belgium respectively ranked number 2, 3 and 4 in this ranking. Lithuania witnessed the best average annual growth at +18.8% per year, while Slovakia was the worst growing country at -8.7% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 46.60 |
2018 | 46.50 |
2017 | 37.90 |
2016 | 29.60 |
2015 | 21.80 |
How does Lithuania rank in Lipid Modifying Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
26 |
#26
Estonia
|
69 | 2019 | +7.3 % | +7.9 % | View data | |
27 |
#27
Lithuania
|
47 | 2019 | +0.2 % | +18.8 % | View data | |
28 |
#28
Turkey
|
23 | 2019 | -3.0 % | +4.7 % | View data |